|
'Atypical' Antidepressants for Bipolar Disorder |
|
|
|
|
Friday, 04 January 2008 |
|
Newer "atypical" antidepressants work differently than other available antidepressants. Currently, none are approved by the FDA to treat bipolar depression. But some evidence suggests they may play a role in treating depression in bipolar disorder. They include: - Wellbutrin (bupropion)
- Effexor (venlafaxine)
- Remeron (mirtazapine)
- Serzone (nefazodone)
Studies have shown that Wellbutrin is effective when added to lithium therapy. However, findings on all of these drugs are still preliminary. Reviewed by the doctors at The Cleveland Clinic Department of Psychiatry and Psychology. VitaDocs Medical Reference provided in collaboration with the Cleveland Clinic
SOURCES: VitaDocs Medical Reference with The Cleveland Clinic: "Bipolar Disorder (Manic Depressive Disorder)." VitaDocs Assess Plus: Bipolar Disorder Assessment. National Institute for Mental Health: "Step-BD Womens Studies." Massachusetts General Hospital Bipolar Clinic & Research Program. MedicineNet.com: "Bipolar Disorder (Mania)." VitaDocs Medical Reference with The Cleveland Clinic: "Effects of Untreated Depression." American Psychiatric Association: "Practice Guideline for the Treatment of Patients With Bipolar Disorder."
Edited by David H. Fram, MD on September 01, 2006 'Portions of this page © The Cleveland Clinic 2000-2005
Trackback(0)
 |
Tags
TrackBack URI for this entry
Subscribe to this comment's feed